Researchers at University of California San Diego School of Medicine, with national collaborators, have identified a series of molecular clues to understanding the formation of cerebral cavernous malformations (CCMs). The study offers the first genome-wide analysis of the transcriptome of brain microvascular endothelial cells after KRIT1 inactivation.
CIPRES, for CyberInfrastructure for Phylogenetic RESearch, is a web-based portal or “gateway” launched by the San Diego Supercomputer Center at UC San Diego that allows researchers to explore evolutionary connections among species. Over 20,000 users from 86 countries have run one or more jobs using CIPRES, generating about 3,500 peer-reviewed publications in journals.
An international team of researchers at University of California San Diego School of Medicine and Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood sample containing circulating tumor DNA.
The Qualcomm Institute at the University of California, San Diego, will save more than $486,650 per year in energy costs thanks to a series of energy-efficiency improvements to Atkinson Hall, where QI is headquartered.
Emma Farley, an assistant professor at UC San Diego’s Division of Biological Sciences and School of Medicine, has been awarded the NIH Director’s New Innovator Award. Melissa Gymrek, an assistant professor in the School of Medicine and Department of Computer Science and Engineering, will receive the NIH Director’s Early Independence Award.
Cell and Developmental Biology Professor Yunde Zhao knows firsthand how grueling the pathway to licensing intellectual property can be. He has gone through the standard licensing procedure in the past and discovered, like many other researchers, that the process to reaching an agreement with commercial partners is no easy feat.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
